2018
DOI: 10.1074/jbc.ra118.001721
|View full text |Cite
|
Sign up to set email alerts
|

PcxL and HpxL are flavin-dependent, oxime-forming N-oxidases in phosphonocystoximic acid biosynthesis in Streptomyces

Abstract: Several oxime-containing small molecules have useful properties, including antimicrobial, insecticidal, anticancer, and immunosuppressive activities. Phosphonocystoximate and its hydroxylated congener, hydroxyphosphonocystoximate, are recently discovered oxime-containing natural products produced by sp. NRRL S-481 and NRRL WC-3744, respectively. The biosynthetic pathways for these two compounds are proposed to diverge at an early step in which 2-aminoethylphosphonate (2AEPn) is converted to ()-1-hydroxy-2-amin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 38 publications
(53 reference statements)
0
12
0
Order By: Relevance
“…Similar approach was used for the isolation of phosphonocystoximate and its hydroxylated derivative (compounds 48 and 49) [24]. Detailed NMR studies on their biosynthesis, which starts from ciliatine and its analog-compound 9, enabled to confirm the presence of intermediates such as mixtures of the (E)-and (Z)-isomers of corresponding oximes (compounds 50 and 51), substrates for the synthesis of phosphonocystoximate and its hydroxylated derivative [95]. They are formed by the action of specific flavin-dependent, oxime-forming N-oxidases.…”
Section: Phosphonopeptide Antibioticsmentioning
confidence: 99%
“…Similar approach was used for the isolation of phosphonocystoximate and its hydroxylated derivative (compounds 48 and 49) [24]. Detailed NMR studies on their biosynthesis, which starts from ciliatine and its analog-compound 9, enabled to confirm the presence of intermediates such as mixtures of the (E)-and (Z)-isomers of corresponding oximes (compounds 50 and 51), substrates for the synthesis of phosphonocystoximate and its hydroxylated derivative [95]. They are formed by the action of specific flavin-dependent, oxime-forming N-oxidases.…”
Section: Phosphonopeptide Antibioticsmentioning
confidence: 99%
“…The catalytic mechanism of CrmH is believed to involve the double hydroxylation of the substrate, caerulomycin N, to form dihydroxylamine, which then dehydrates and tautomerizes to form the oxime-containing caerulomycin A. Caerulomycin A has a unique 2,2 ′ -bipyridine skeleton and shows attractive potential bioactivities such as antifungal, antiamoebic, and antitumor [62] properties. In Streptomyces species, PcxL and Hpx catalyze similar oxidation reactions of 2-aminoethylphosphonate (2AEPn) and (R)-1H2AEPn, respectively, to corresponding aldoximes, which are further oxidized to nitrosylated phosphonic acid products through multiple steps [66]. Oxime-containing small molecules are reported to have interesting biological properties such as antibacterial, antifungal, insecticidal, antitumor, immunosuppressive, and acetylcholinesterase reactivation activities [66].…”
Section: Double Hydroxylation Reactions By Novel Nmosmentioning
confidence: 99%
“…In Streptomyces species, PcxL and Hpx catalyze similar oxidation reactions of 2-aminoethylphosphonate (2AEPn) and (R)-1H2AEPn, respectively, to corresponding aldoximes, which are further oxidized to nitrosylated phosphonic acid products through multiple steps [66]. Oxime-containing small molecules are reported to have interesting biological properties such as antibacterial, antifungal, insecticidal, antitumor, immunosuppressive, and acetylcholinesterase reactivation activities [66].…”
Section: Double Hydroxylation Reactions By Novel Nmosmentioning
confidence: 99%
“…Dehydrophos consists of a glycineleucin dipeptide bound to an O-methylated aminovinylphosphonate, its dehydrophosphorylation proceeds analogously to the similar in structure alaphosphine peptide and the Trojan horse peptide dehydrophosphine is imported and cleaved by peptide permeases and peptidases, respectively, to release the alanine racemase inhibitor within the cell (Figure 58) [179,180]. In recent years, a number of P-C antibiotics, possessing antifungal activity: rhizocticins [139,180], phosphonocystoximic acid [181], plumbemycins [139,182], phosphacetamycin [183], have been isolated from Bacillus subtilis and Streptomyces plumbeus. They represent di-and tripeptides containing the C-terminal (Z)-L-2-amino-5-phosphono-3pentenoic acid, a phosphonotreonine mimetic [184], reminiscent of dehydrophos as a broad-spectrum antibiotic that acts against infection of Salmonella [185].…”
Section: Natural Organophosphorus Compounds With P-c Bondmentioning
confidence: 99%